OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of miR-25 improves cardiac contractility in the failing heart
Christine Wahlquist, Dongtak Jeong, Agustin Rojas‐Muñoz, et al.
Nature (2014) Vol. 508, Iss. 7497, pp. 531-535
Open Access | Times Cited: 398

Showing 51-75 of 398 citing articles:

Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction
Shunsuke Eguchi, Mikito Takefuji, Teruhiro Sakaguchi, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 31, pp. 11665-11674
Open Access | Times Cited: 87

From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases
Ulf Landmesser, Wolfgang Poller, Sotirios Tsimikas, et al.
European Heart Journal (2020) Vol. 41, Iss. 40, pp. 3884-3899
Open Access | Times Cited: 79

Small non-coding RNA therapeutics for cardiovascular disease
Ajay M. Shah, Mauro Giacca
European Heart Journal (2022) Vol. 43, Iss. 43, pp. 4548-4561
Open Access | Times Cited: 54

Signaling cascades in the failing heart and emerging therapeutic strategies
Xin He, Tailai Du, Tianxin Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 47

Calcium dysregulation in heart diseases: Targeting calcium channels to achieve a correct calcium homeostasis
Giampaolo Morciano, Alessandro Rimessi, Simone Patergnani, et al.
Pharmacological Research (2022) Vol. 177, pp. 106119-106119
Closed Access | Times Cited: 39

Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development
Timothy A. McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3482-3498
Open Access | Times Cited: 39

The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy
Santosh K. Sanganalmath, Shubham Dubey, Sudhakar Veeranki, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29

MiRNA inhibition in tissue engineering and regenerative medicine
Kelsey R. Beavers, Christopher E. Nelson, Craig L. Duvall
Advanced Drug Delivery Reviews (2014) Vol. 88, pp. 123-137
Open Access | Times Cited: 86

MiR-25 Protects Cardiomyocytes against Oxidative Damage by Targeting the Mitochondrial Calcium Uniporter
Lei Pan, Bijun Huang, Xiue Ma, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 3, pp. 5420-5433
Open Access | Times Cited: 83

Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy
Tania Zaglia, Paola Ceriotti, Antonio Fuente del Campo, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 43
Open Access | Times Cited: 82

A myriad of roles of miR-25 in health and disease
Márta Sárközy, Zsuzsanna Kahán, Tamás Csont
Oncotarget (2018) Vol. 9, Iss. 30, pp. 21580-21612
Open Access | Times Cited: 82

Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer
Zhongliang Ma, Bing-Jie Zhang, De-Tao Wang, et al.
Oncotarget (2015) Vol. 6, Iss. 24, pp. 20111-20120
Open Access | Times Cited: 80

Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function
Jorge Suárez, Federico Cividini, Brian T. Scott, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 21, pp. 8182-8195
Open Access | Times Cited: 80

miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy
Jae Gyun Oh, Shin Watanabe, Ah Young Lee, et al.
Circulation Research (2018) Vol. 123, Iss. 6, pp. 673-685
Open Access | Times Cited: 80

MicroRNAs in cardiovascular disease
Priyatansh Gurha
Current Opinion in Cardiology (2016) Vol. 31, Iss. 3, pp. 249-254
Closed Access | Times Cited: 76

Screening of Pre-miRNA-155 Binding Peptides for Apoptosis Inducing Activity Using Peptide Microarrays
Jaeyoung Pai, Soonsil Hyun, Ji Young Hyun, et al.
Journal of the American Chemical Society (2016) Vol. 138, Iss. 3, pp. 857-867
Closed Access | Times Cited: 71

Circulating microRNA‐132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure
Serge Masson, Sándor Bátkai, Julia Beermann, et al.
European Journal of Heart Failure (2017) Vol. 20, Iss. 1, pp. 78-85
Open Access | Times Cited: 67

miRNA in cardiac development and regeneration
Zhaohui Ouyang, Ke Wei
Cell Regeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 53

Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger
Anshul S. Jadli, Ananya Parasor, Karina Pereira Gomes, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 51

Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca 2+ -ATPase Expression in Cardiomyocytes
Mortimer Korf‐Klingebiel, Marc R. Reboll, Felix Polten, et al.
Circulation (2021) Vol. 144, Iss. 15, pp. 1227-1240
Open Access | Times Cited: 46

Scroll to top